StockWatch
·

NATCO PHARMA LTD.

BSE: 524816

Shareholding Trends

Ownership split

PromoterPublicOthers
0%23%47%70%Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Institutional detail

FII / FPIDII
4%9%14%19%Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Q4 FY2026

Corporate Events

Board MeetingNATCOPHARM
2026
29May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing
Board MeetingNATCOPHARM
2026
24Mar

Board Meeting

To consider and approve the Scheme of Arrangement for the de…

BSE Filing
DividendNATCOPHARM
2025
20Nov

₹1.5 / share

BSE Filing
DividendNATCOPHARM
2025
18Feb

₹1.5 / share

BSE Filing
DividendNATCOPHARM
2025
12Feb

₹3 / share

BSE Filing
DividendNATCOPHARM
2024
25Nov

₹1.5 / share

BSE Filing
DividendNATCOPHARM
2024
23Aug

₹3 / share

BSE Filing
Board MeetingNATCOPHARM
2024
27May

Board Meeting

Approval of the Audited Financial Results for the quarter an…

BSE Filing
DividendNATCOPHARM
2024
26Feb

₹1.25 / share

BSE Filing
Board MeetingNATCOPHARM
2024
14Feb

Board Meeting

Consideration of Unaudited Financial Results for the quarter…

BSE Filing
DividendNATCOPHARM
2023
24Nov

₹1.25 / share

BSE Filing
Board MeetingNATCOPHARM
2023
14Nov

Board Meeting

consideration and approval of The Unaudited Financial Result…

BSE Filing
DividendNATCOPHARM
2023
22Aug

₹7 / share

BSE Filing
DividendNATCOPHARM
2023
9Aug

₹7 / share

BSE Filing